Skip to main content

Regulatory and Washington

  • Actavis can launch generic painkiller in May 2014 under settlement

    PARSIPPANY, N.J. — Actavis and Mallinckrodt have reached a settlement concerning the former's generic version of an opioid painkiller made by the latter, Actavis said Thursday.

    The companies settled patent lawsuit regarding Actavis' generic version of Mallinckrodt's Exalgo (hydromorphone hydrochloride) extended-release tablets in the 32-mg strength. The companies settled litigation regarding the 8-mg, 12-mg and 16-mg strengths last month.

  • Small increase in January retail sales indicate 'stable yet fragile economy,' NRF says

    WASHINGTON — Retail sales were up slightly in January as the increases in payroll taxes and energy prices forced consumers to change spending habits, according to a new report by the National Retail Federation.

  • NACDS touts pharmacists' role in vaccinations for House subcommittee hearing

    ARLINGTON, Va. — The National Association of Chain Drug Stores made its voice heard in the U.S. House of Representatives Energy and Commerce Subcommittee on Oversight and Investigations on the role of pharmacists in influenza vaccination, the retail pharmacy lobbying group said Wednesday.

  • FDA gives breakthrough therapy designations to experimental cancer drug

    RARITAN, N.J. — The Food and Drug Administration has given a special designation to a cancer drug under development by Johnson & Johnson and Pharmacyclics, the companies said.

    J&J subsidiary Janssen Research & Development and Pharmacyclics announced that the FDA had given breakthrough therapy designations to the experimental drug ibrutinib as a standalone therapy for relapsed or refractory mantle cell lymphoma in patients who have received prior therapy and for Waldenstrom's macroglobulinemia.

  • NCPA outlines legislative priorities

    ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday announced its federal and state legislative priorities with the release of the Independent Community Pharmacy Checklist. The one-page document details the main legislative actions NCPA and its members will advocate for this year at the federal and state levels. 

  • Persistent shortage of primary care, specialist physicians found in New York state

    ALBANY, N.Y. — A new report indicates that a shortage of physicians could adversely affect the implementation of healthcare reform.

  • Nearly 90 representatives call on USPS to preserve Saturday delivery of medications

    WASHINGTON — More than seven dozen members of the House of Representatives are urging the U.S. Postal Service to continue delivering medications to all Americans six days a week.

  • State of the Union address draws mixed responses from drug industry

    WASHINGTON — Some people liked President Barack Obama's State of the Union address Tuesday night, and some people didn't, and the response from the drug industry was no less mixed.

    The Generic Pharmaceutical Association called for measures to lower healthcare costs, including ensuring that generic pharmaceuticals and biosimilars reach patients' hands quickly and also avoiding measures intended to provide savings that the GPhA said would raise prescription drug costs, though the grow didn't specify what those measures were.

X
This ad will auto-close in 10 seconds